omniture
logo
Search
Huahui Health Ltd.
Media Room

Latest News

rss

Libevitug Approved in China as First-in-Class Treatment for Hepatitis D

BEIJING, Jan. 27, 2026 /PRNewswire/ -- Huahui Health announced that China National Medical Products...

2026-01-27 16:18 5086
Libevitug Approved in China as First-in-Class Treatment for Hepatitis D

Libevitug Approved in China as First-in-Class Hepatitis D Treatment

BEIJING, Jan. 27, 2026 /PRNewswire/ -- Huahui Health announced that China's National Medical Produc...

2026-01-27 16:15 5744
Libevitug Approved in China as First-in-Class Hepatitis D Treatment

FDA Grants Breakthrough Therapy Designation to Huahui Health's Libevitug (HH-003) for treatment of chronic Hepatitis D virus infection

BEIJING, Nov. 18, 2024 /PRNewswire/ -- Huahui Health, a clinical-stage biotechnology company focuse...

2024-11-18 18:40 2012

Huahui Health to Present Preclinical Data of HH018-sesutecan at the 2024 AACR Annual Meeting

BEIJING, April 4, 2024 /PRNewswire/ -- Huahui Health Ltd.("Huahui Health"), a clinical stage biotec...

2024-04-04 22:00 2736